By combining all the data, we found that patients with high expression of SATB1 tended to have shorter OS and SATB1 was correlated with tumor differentiation, distant metastasis and lymph node metastasis. The gene discussed is SATB1; the disease is metastatic malignant neoplasm in the lymph nodes.